Ischemic Stroke: Clinical Trials

55 trials for Ischemic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 unknown. 55 Phase 3, 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 355Unknown 55
Phase 217Unknown 17

Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
Ticagrelor Versus Cilostazol in Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002024-08-302024-08-20
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit - Ischemic Stroke, Acute
Phase 3UnknownBeijing Tiantan Hospital6002024-08-102024-10-01
Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University5802024-03-302024-08-20
Cerebroprotective Effect of Melatonin in Stroke
Melatonin 10 MG, Placebo - Stroke, Acute Ischemic, Strokes Thrombotic
Phase 3UnknownCoordinación de Investigación en Salud, Mexico1002024-03-012024-03-05
GD-11 for Injection in the Treatment of Acute Ischemic Stroke
GD-11 for injection test group, Placebo control group - Acute Ischemic Stroke
Phase 3UnknownBeijing Tiantan Hospital9802024-02-292024-03-15
Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis
Rivaroxaban, Clopidogrel, Aspirin - Ischemic Stroke, Intracranial Atherosclerosis
Phase 2 / Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University11802023-12-302023-12-21
Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002023-12-012024-08-20
Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy
Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin - Acute Ischemic Stroke
Phase 3UnknownTianjin Huanhu Hospital802023-09-072023-11-02
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L)
Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) - Acute Ischemic Stroke
Phase 3UnknownJi Xunming,MD,PhD12302023-08-172024-03-28
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
Edaravone Dexborneol Concentrated Solution for injection, Edaravone Dexborneol placebo - Ischemic Stroke, Acute, Treatment Outcome
Phase 3UnknownXiangya Hospital of Central South University2122023-07-012023-06-27
NanO2 for Large Vessel Occlusion Stroke
Placebo, dodecafluoropentane emulsion (DDFPe) - Ischemic Stroke
Phase 2 / Phase 3UnknownNuvOx LLC3002023-04-012022-05-25
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
Intravenous thrombolysis agents, endovascular thrombectomy - Stroke, Acute Ischemic
Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine2222022-12-032023-02-14
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)
Alteplase, Tenecteplase - Acute Ischemic Stroke
Phase 3UnknownBeijing Tiantan Hospital16302022-10-262023-02-27
Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS)
Yiqihuayu Decotion - Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownYing Gao152022-09-252022-09-29
Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
Tenecteplase - Acute Ischemic Stroke
Phase 3UnknownHospital Universitari Vall d'Hebron Research Institute5002022-05-272022-11-25
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
Cilostazol 100 MG, Clopidogrel - Ischemic Stroke
Phase 3UnknownKafrelsheikh University8702022-05-012024-09-19
Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA
Ticagrelor 90 MG, Clopidogrel - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002022-05-012024-09-19
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Cilostazol 100 MG, Clopidogrel 75mg - Ischemic Stroke
Phase 3UnknownKafrelsheikh University8702022-04-152024-09-19
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002022-02-092024-09-19

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Stroke (16)  ·  Carotid Stenosis (1)  ·  Cerebral Infarction (1)  ·  Cerebral Palsy (1)  ·  Cognitive Dysfunction (1)  ·  Constriction, Pathologic (1)  ·  Dehydration (1)  ·  Dementia, Vascular (1)  ·  Disease Progression (1)  ·  Intracranial Arteriosclerosis (1)  ·  Ischemic Attack, Transient (1)  ·  Metabolic Syndrome (1)  ·  Moyamoya Disease (1)  ·  Paresis (1)

Broader conditions

Brain Diseases (55)  ·  Cardiovascular Diseases (55)  ·  Central Nervous System Diseases (55)  ·  Cerebrovascular Disorders (55)  ·  Nervous System Diseases (55)  ·  Vascular Diseases (55)  ·  Stroke (39)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Arterial Occlusive Diseases (4)  ·  Intracranial Arterial Diseases (3)  ·  Pathologic Processes (3)  ·  Arteriosclerosis (2)  ·  Brain Ischemia (2)  ·  Carotid Artery Diseases (2)  ·  Metabolic Diseases (2)

Interventions

Aspirin (9)  ·  Clopidogrel (8)  ·  Cilostazol (6)  ·  Ticagrelor (5)  ·  Saline Solution (3)  ·  Tenecteplase (3)  ·  Atorvastatin (2)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (2)  ·  Rivaroxaban (2)  ·  Tirofiban (2)  ·  apixaban (2)  ·  cerebrolysin (2)  ·  3-n-butylphthalide (1)  ·  Albumins (1)  ·  Biguanides (1)

Sponsors

Kafrelsheikh University (7)  ·  Beijing Tiantan Hospital (3)  ·  Samsung Medical Center (3)  ·  Capital Medical University (2)  ·  Fudan University (2)  ·  Shanghai Yueyang Integrated Medicine Hospital (2)  ·  Xijing Hospital (2)  ·  Ain Shams University (1)  ·  Assiut University (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chonnam National University Hospital (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Duta Wacana Christian University (1)  ·  Eighth Affiliated Hospital, Sun Yat-sen University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Countries

China (19)  ·  Egypt (8)  ·  South Korea (5)  ·  United States (5)  ·  Mexico (2)  ·  Norway (2)  ·  Poland (2)  ·  Spain (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)

Top investigators

Oh Young Bang, MD (3)  ·  Gang Zhao, M.D. (2)  ·  Shuya Li (2)  ·  Adam Kirton, MD MSc FRCPC (1)  ·  Anne W Alexandrov, PhD (1)  ·  Bin Peng, MD (1)  ·  Ellen M Whyte, MD (1)  ·  Ellisiv B Mathiesen (1)  ·  Guifu Wu, PhD (1)  ·  JT Yang, PHD (1)

Results publications

PMID 18190818, PMID 2375765, PMID 31867054, PMID 38648030, PMID 11315017, PMID 11673584, PMID 11914403, PMID 12807523, PMID 1884569, PMID 20110753, PMID 20204386, PMID 22105690, PMID 23040716, PMID 24083670, PMID 25487817, PMID 25748452, PMID 26386103, PMID 26458895, PMID 27029628, PMID 28082671, PMID 28095900, PMID 28612680, PMID 28950419, PMID 29016744, PMID 29127270, PMID 29371333, PMID 29446769, PMID 29573529, PMID 29720439, PMID 30511260, PMID 30761076, PMID 31122494, PMID 31236801, PMID 31248555, PMID 31337525, PMID 31535829, PMID 31570084, PMID 31645472, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32295510, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33446083, PMID 33449944

NIH funding

2014 (1), R01NR017850 (1)